Science Explorer Back to mapMap
Discussion
Researcher · Octapharma (United States) · United States

Lev Sverdlov

Lev Sverdlov publishes mostly in Psychiatry and Mental health, Pharmacology and Statistics and Probability, on topics such as Treatment of Major Depression, Bipolar Disorder and Treatment and Statistical Methods in Clinical Trials.

OpenAlex
World rank
#7,112,519
of 7,710,434 ranked researchers
Rank in United States
#1,584,214
of 1,627,098
Works
23
Citations
333
Citations per work
14.5
h-index
9
i10-index 9Top 69% in Psychiatry and Mental health
Lev Sverdlov

What does Lev Sverdlov research?

Lev Sverdlov's work is mostly in Medicine (31%), Neuroscience (15%), Mathematics (8%).

Everything else: 9 works · 37.1% of their workHealth Sciences: 7 works · 30.6% of their workMedicine: 7 works · 30.6% of their workPharmacology: 4 works · 15.3% of their workPsychiatry and Mental health: 4 works · 15.3% of their workLife Sciences: 4 works · 15.3% of their workNeuroscience: 4 works · 15.3% of their workCognitive Neuroscience: 2 works · 8.5% of their workCellular and Molecular Neuroscience: 2 works · 6.8% of their workPhysical Sciences: 2 works · 8.5% of their workMathematics: 2 works · 8.5% of their workStatistics and Probability: 2 works · 8.5% of their workSocial Sciences: 2 works · 8.5% of their workPsychology: 2 works · 8.5% of their workExperimental and Cognitive Psychology: 2 works · 8.5% of their workTHEIR WORKLev Sverdlov23works
Life Sciences15%Physical Sciences8%Health Sciences31%Social Sciences8%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else937.1%
    1. Medicine730.6%
    1. Neuroscience415.3%
    1. Mathematics28.5%
    1. Psychology28.5%
  1. 1Psychiatry and Mental health15% of their works
  2. 2Pharmacology15% of their works
  3. 3Statistics and Probability8% of their works
  4. 4Experimental and Cognitive Psychology8% of their works
  5. 5Cognitive Neuroscience8% of their works
  6. 6Cellular and Molecular Neuroscience7% of their works

Research topics

Which keywords describe Lev Sverdlov's research?

The keywords of their largest research topics: Depression, Antidepressant, Ketamine, Bipolar Spectrum Disorder, Prevalence, Adaptive Designs, False Discovery Rate and Brain-Computer Interfaces.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Depression102 topics
  2. Antidepressant81 topic
  3. Ketamine81 topic
  4. Bipolar Spectrum Disorder61 topic
  5. Prevalence61 topic
  6. Adaptive Designs31 topic
  7. False Discovery Rate31 topic
  8. Brain-Computer Interfaces21 topic
  9. Carbene Chemistry21 topic
  10. Causal Inference21 topic
  11. Cyclopropanation21 topic
  12. Cytokines21 topic
  13. Dopamine21 topic
  14. EEG Analysis21 topic
  15. Neuroinflammation21 topic
  16. Propensity Score21 topic
  17. Serotonin21 topic

Where does Lev Sverdlov work?

Lev Sverdlov's main affiliation in the publication record is Octapharma (United States), United States.

How many publications and citations does Lev Sverdlov have?

OpenAlex counts 23 works and 333 citations for Lev Sverdlov, an h-index of 9, ranking #7,112,519 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Lev Sverdlov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.